Fourth Quarter and Year End 2018 Financial Results Conference Call

Skip to main content Skip to section navigation Skip to footer

Product Indications

VIVEVE®️ SYSTEM

In the United States the Viveve System is cleared by the FDA for general surgery procedures for electrocoagulation and hemostasis.

The Viveve System has received regulatory approvals and clearances in many countries throughout the world and is available through physician import license in Japan and China. International approvals and clearances include vaginal laxity and/or improvement of sexual function indications. In Argentina improvement of urinary incontinence in women is also an approved indication.

Investor Relations

Fourth Quarter and Year End 2018 Financial Results Conference Call

Earnings Release

PDF HTML

10-K

PDF HTML

XBRL

ZIP XLS